Muscarinic properties of compounds related to arecaidine propargyl ester

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 1, 2000, Pages 11-15

  Tumiatti, Vincenzo ^a   Wehrle, Jahn ^b   Hildebrandt, Caren ^b   Moser, Ulrich ^b   Dannhardt, Gerd ^c   Mutschler, Ernst ^b   Lambrecht, Günter ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b GOETHE UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Arecaidine propargyl ester analogues, structure activity relationship; CAS 35516 99 5; Muscarinic receptor subtypes

Indexed keywords

11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; ARECAIDINE PROPARGYL ESTER; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR AGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GUINEA PIG; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PHARMACOLOGICAL STIMULATION; RABBIT; STRUCTURE ACTIVITY RELATION;

EID: 0033959691     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300157     Document Type: Article

References (22)

1. [1] Buckley, N. J., Bonner, I., Buckley, C. M. et al., Mol. Pharmacol. 35, 469 (1989)
2. [2] Dörje, F., Wess, J., Lambrecht, G. et al., J. Pharmacol. Exp. Ther. 256, 727 (1991)
3. [3] Caulfield, M. P., Birdsall, N. J. M., Pharmacol. Rev. 50, 279 (1998)
4. [4] Mutschler, E., Hultzsch, K., Arzneim.-Forsch./Drug Res. 23, 732 (1973)
5. [5] Moser, U., Lambrecht, G., Wagner, M. et al., Br. J. Pharmacol. 96, 319 (1989)
6. [6] Gloge, H., Lüllmann, H., Mutschler, E., Br. J. Pharmacol. Chemother. 27, 185 (1966)
7. [7] Christiansen, A., Lüllmann, H., Mutschler, E., Eur. J. Pharmacol. 1, 81 (1967)
8. [8] Kummer, B., Lüllmann, H., Mutschler, E., Naunyn-Schmiedeberg's Arch. Pharmak. Exp. Path. 154, 159 (1966)
9. [9] Porsius, A. J., Mutschler, E., Van Zwieten, P. A., Arzneim.-Forsch./Drug Res. 28 (II), 1373 (1978)
10. [10] Chilton, J., Stenlake, J. B., J. Pharm. Pharmacol. 14, 350 (1962)
11. [11] Smith, R. A., White, R. L., Krantz, A., J. Med. Chem. 31, 1558 (1988)
12. [12] Bailey, W. J., Pfeifer, C. R., J. Org. Chem. 20, 1337 (1955)
13. [13] Denmark, S. E., Harmata, M. A., White, K. S., J. Org. Chem. 52, 4031 (1987)
14. [14] Jones, E. R. H., Thompson, J. M., Whiting, M. C., J. Chem. Soc. 2012 (1957)
15. [15] Eltze, M., Gmelin, G., Wess, J. et al., Eur. J. Pharmacol. 158, 233 (1988)
16. [16] Arunlakshana, O., Schild, H. O., Br. J. Pharmacol. 14, 48 (1959)
17. [17] Tallarida, R. J., Murray, R. B., Manual of Pharmacological Calculations with Computer Programs, Springer Verlag, New York (1991)
18. [18] Eltze, M., Eur. J. Pharmacol. 151, 205 (1988)
19. [19] Dörje, F., Rettenmayr, N. M., Mutschler, E. et al., Eur. J. Pharmacol. 203, 417 (1991)
20. [20] Lambrecht, G., Moser, U., Grimm, U. et al., Life Sci. 51, 481 (1993)
21. [21] Wehrle, J., Moser, U., Tumiatti, V. et al., 10th Camerino-Noordwijkerhout Symposium, Camerino (Italy), September 1995, book of abstracts, P7 (1995)
22. [22] Paton, W. D. M., Zar, M. A., J. Physiol. (London) 194, 13 (1968)